# Chongqing Xishan Science & Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chongqing-xishan-science-technology-co

- Industry: Medical Devices & Equipment
- Headquarters: Chongqing, China
- Website: www.xishantech.com.cn
- Total disclosed funding: $17M
- Latest round: Series D (Dec 13, 2021)
- Investors on record: 5

## About

Established in 1999, and based in Chongqing, China, Chongqing Xishan Science & Technology Co., Ltd. is a medical equipment company that specializes in the research and development, manufacture, sales and service of digital minimally invasive surgical devices and medical consumables. It has multiple offices in North America & Europe, South America, Africa & Middle East, and Eurasia. As of December 2022, it has over 900 patents, 6 registration certificates for Class III medical devices and over 40 registration certificates for Class II medical devices. In 2011, its products received CE certification. In 2015, it invented the suspended & sheathed saw for endoscope and energy surgical equipment. In 2017, its endoscope factory with phase I was completed and put into use. In 2020, it launched the VBB system. And in June 2023, it was listed on the Sci-Tech Innovation Board under the number 688576. 


Its products can be divided into surgical power devices, endoscopic systems, ultrasonic bone scalpels, VABB breast biopsy, plasma surgical devices, and WFNS drill sets. The surgical power device can be used for orthopaedic, spine & arthroscopic surgery. The ultrasonic bone scalpels can be used for cutting & shaving bone tissues in spine surgery. And plasma surgical devices can be treated for chronic hypertrophy rhinitis, turbinate hypertrophy, and allergic rhinitis.

## Funding rounds

- Series D, Dec 13, 2021, $16M — Shanghai Jianyi Private Equity Fund Management, Jinyuan Kuntong Equity Investment Management
- Series C, May 21, 2015, $1.6M — Hina Group, Trust China
- Series B, Oct 24, 2013 — Hina Group
- Series A, Jun 6, 2012 — ChinaRun Partners

## Investors

- ChinaRun Partners (https://capitalatlas.ai/funds/chinarun-partners) — Series A
- Hina Group (https://capitalatlas.ai/funds/hina-group) — Series B, Series C
- Trust China (https://capitalatlas.ai/funds/trust-china) — Series C
- Shanghai Jianyi Private Equity Fund Management (https://capitalatlas.ai/funds/shanghai-jianyi-private-equity-fund-management) — Series D
- Jinyuan Kuntong Equity Investment Management (https://capitalatlas.ai/funds/jinyuan-kuntong-equity-investment-management) — Series D